JP2018518151A5 - - Google Patents

Download PDF

Info

Publication number
JP2018518151A5
JP2018518151A5 JP2017550485A JP2017550485A JP2018518151A5 JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5 JP 2017550485 A JP2017550485 A JP 2017550485A JP 2017550485 A JP2017550485 A JP 2017550485A JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5
Authority
JP
Japan
Prior art keywords
seq
antibody
acid sequence
isolated
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017550485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518151A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/024357 external-priority patent/WO2016160620A2/en
Publication of JP2018518151A publication Critical patent/JP2018518151A/ja
Publication of JP2018518151A5 publication Critical patent/JP2018518151A5/ja
Withdrawn legal-status Critical Current

Links

JP2017550485A 2015-03-27 2016-03-25 Ｂ７−ｈ４発現充実性腫瘍を処置するためのｃａｒ ｔ細胞 Withdrawn JP2018518151A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562139592P 2015-03-27 2015-03-27
US62/139,592 2015-03-27
PCT/US2016/024357 WO2016160620A2 (en) 2015-03-27 2016-03-25 Car t-cells for the treatment of b7-h4 expressing solid tumors

Publications (2)

Publication Number Publication Date
JP2018518151A JP2018518151A (ja) 2018-07-12
JP2018518151A5 true JP2018518151A5 (OSRAM) 2019-05-09

Family

ID=57007182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017550485A Withdrawn JP2018518151A (ja) 2015-03-27 2016-03-25 Ｂ７−ｈ４発現充実性腫瘍を処置するためのｃａｒ ｔ細胞

Country Status (8)

Country Link
US (1) US20180118831A1 (OSRAM)
EP (1) EP3274369A4 (OSRAM)
JP (1) JP2018518151A (OSRAM)
CN (1) CN107531782A (OSRAM)
AU (1) AU2016243126A1 (OSRAM)
CA (1) CA2981143A1 (OSRAM)
IL (1) IL254700A0 (OSRAM)
WO (1) WO2016160620A2 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10814011B1 (en) 2017-06-16 2020-10-27 Nantbio, Inc. Anti-B7-H4 antibodies and methods
CA3067914A1 (en) 2017-06-30 2019-01-03 Cellectis Cellular immunotherapy for repetitive administration
TWI817952B (zh) 2017-08-25 2023-10-11 美商戊瑞治療有限公司 Ｂ７－ｈ４抗體及其使用方法
CN107903326B (zh) * 2018-01-02 2020-06-30 广东省人民医院(广东省医学科学院) 包含C3aR胞内结构域的嵌合抗原受体、慢病毒载体、表达细胞及药物
KR20260053095A (ko) * 2018-02-11 2026-04-20 장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 항 비7 에이치4 항체, 그의 항원 결합 단편 및 그의 약학적 용도
BR112020016986A2 (pt) 2018-02-21 2021-03-02 Five Prime Therapeutics, Inc. formulações de anticorpo contra b7-h4
CA3091801A1 (en) 2018-03-02 2019-09-06 Five Prime Therapeutics, Inc. B7-h4 antibodies and methods of use thereof
AU2020242794B2 (en) * 2019-03-21 2024-02-01 Beijing Kanova Biopharmaceutical Co., Ltd. Anti-B7S1 polypeptides and their use
CA3115917A1 (en) * 2019-08-01 2021-02-04 Nantkwest, Inc. Anti-b7-h4 chimeric antigen receptor-modified nk-92 cells
US20230192807A1 (en) * 2020-05-15 2023-06-22 Precision Biosciences, Inc. Methods for immunotherapy
JP2024500847A (ja) 2020-12-18 2024-01-10 センチュリー セラピューティクス，インコーポレイテッド 適合可能な受容体特異性を有するキメラ抗原受容体システム
CN113156120B (zh) * 2021-03-26 2022-03-25 中国医学科学院北京协和医院 B7h4在制备子宫内膜癌分子分型试剂及系统中的应用
US20250136694A1 (en) * 2021-08-18 2025-05-01 Harbour Biomed (Shanghai) Co., Ltd Anti-b7-h4 antibody, and preparation method therefor and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468546B1 (en) * 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
AU2005306997B2 (en) * 2004-10-25 2012-07-05 Merck Sharp & Dohme Corp. Anti-ADDL antibodies and uses thereof
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
WO2010138564A1 (en) * 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Of New York University Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
US9422351B2 (en) * 2011-11-03 2016-08-23 The Trustees Of The University Of Pennsylvania Isolated B7-H4 specific compositions and methods of use thereof
WO2013130565A1 (en) * 2012-02-29 2013-09-06 The Brigham And Women's Hosptial, Inc. Neutralizing antibody for epstein barr virus associated disease
JP2015533832A (ja) * 2012-10-09 2015-11-26 アイジェニカ バイオセラピューティクス インコーポレイテッド 抗Ｃ１６ｏｒｆ５４抗体およびその使用方法
JP2016509582A (ja) * 2012-12-19 2016-03-31 アンプリミューン， インコーポレイテッド 抗ヒトｂ７−ｈ４抗体およびその使用
EP3299391B1 (en) * 2013-03-14 2019-12-04 Genentech, Inc. Anti-b7-h4 antibodies and immunoconjugates
JP6288621B2 (ja) * 2013-08-23 2018-03-07 学校法人藤田学園 インフルエンザウイルスに対する抵抗力の判定方法

Similar Documents

Publication Publication Date Title
JP2018511319A5 (OSRAM)
KR102924006B1 (ko) 항-pd-l1/항-4-1bb 이중특이적 항체 및 이의 용도
Fisher et al. Generation and preclinical characterization of an antibody specific for SEMA4D
TWI878541B (zh) 抗ｃｌｄｎ１８.２抗體及其診斷用途
CN112189021A (zh) 抗b7-h3抗体及其用途
JP2018524973A5 (OSRAM)
JP2012012402A5 (OSRAM)
JP2018518152A5 (OSRAM)
CN111995682B (zh) 抗人SIRPα单克隆抗体及其用途
JP2013506428A5 (OSRAM)
JP2014527398A5 (OSRAM)
CN113683697B (zh) 抗b7-h3抗体、其制备方法及用途
KR20190034236A (ko) 항 b7-h4 항체
JP2018505681A5 (OSRAM)
WO2021097800A1 (en) Anti-pd-l1/anti-b7-h3 multispecific antibodies and uses thereof
JP2022548777A5 (OSRAM)
JP2020513769A (ja) 抗ｌａｉｒ１抗体およびその使用
CN111620949A (zh) 结合人lag-3的抗体、其制备方法和用途
WO2018162944A1 (en) Recombinant antibodies to programmed death 1 (pd-1) and uses therefor
CN118108853A (zh) Cd47/4-1bb结合蛋白及其医药用途
JPWO2014192974A1 (ja) 抗ｌｇｒ６抗体を含む癌の検出用又は診断用試薬
JPWO2010117059A1 (ja) 形質細胞の腫瘍性増殖をきたす疾患の治療薬
JP7082112B2 (ja) 抗ｇｐｒ２０抗体
CN113527484A (zh) 抗cd47单克隆抗体
JP2025506203A5 (OSRAM)